Fludase - Experimental Antiviral Drug for Influenza

 

Key Data:

Drug (Brand/Generic)
Fludase (DAS181)
Company/Licensee
NexBio
Therapy Class
Anti-viral agent
Product Description
Recombinant sialidase fusion protein
Current Indication
Treatment of influenza
Market Sector
Anti-infectives
Development Status
Phase II

Return to Fludase - Experimental Antiviral Drug for Influenza Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development